Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCerillion Regulatory News (CER)

Share Price Information for Cerillion (CER)

Share Price is delayed by 15 minutes
Get Live Data
1110.00    -20.00 (-1.79%)
Bid:
1100.00
Ask:
1120.00
Spread: 20.00 (1.818%)
Market Cap: £324.95m
CER Live PriceLast checked at - London Stock Exchange

Intraday Cerillion Share Chart

Full Year Trading Update

23 Oct 2025 07:00

RNS Number : 4223E
Cerillion PLC
23 October 2025
 

AIM: CER

 

 Cerillion plc

("Cerillion" or "the Company")

 

Full Year Trading Update

 

Cerillion, the billing, charging and customer relationship management software solutions provider, is pleased to announce an update on trading for the financial year ended 30 September 2025.

 

The Company traded well over the second half of its financial year, securing two major follow-on contracts, with an existing European customer in September 2025, after signing a major new services agreement with that customer in May 2025. At a combined £25.3 million over five years, they are amongst Cerillion's largest contract wins.

 

The wins helped to take total new orders signed in the financial year to a record high of £47.6m, 25% higher than the prior year. It reflects both new customer additions and the growing value of the installed base. Revenue for the financial year is expected to be approximately £45.3m (2024: £43.8m), reflecting the timing of contract wins, and adjusted profit before tax is expected to be slightly ahead of the consensus market forecast of £20.5m (2024: adjusted profit before tax of £19.8m). The balance sheet remains very strong, with net cash at the financial year-end increased to £34.4m (30 September 2024: £29.9m).

 

The Company enters the new financial year with both a strong back-order book* and a very strong sales pipeline, which includes some substantial opportunities. The Board therefore continues to view growth prospects very positively.

 

Notice of Results

Full year results are expected to be reported in late November 2025, when the Company will also provide a further update on current trading. 

 

*Back-order book consists of sales contracted but not yet recognised as revenue at the end of the reporting period plus annualised support and maintenance revenue.

Enquiries:

Cerillion plc

c/o KTZ Communications

Louis Hall, CEO

T: 020 3178 6378

Andrew Dickson, CFO

Panmure Liberum (Nomad and Broker)

T: 020 3100 2000

Bidhi Bhoma, Edward Mansfield, Shalin Bhamra, Freddie Wooding

Singer Capital Markets (Joint Broker)

T: 020 7496 3000

Rick Thompson, James Fischer

KTZ Communications

T: 020 3178 6378

Katie Tzouliadis, Robert Morton

 

About Cerillion

www.cerillion.com

 

Cerillion is a leading provider of mission critical software for billing, charging and customer relationship management ("CRM"), mainly serving the telecommunications market but also other sectors such as utilities and financial services. The Company currently has c.70 customer installations across c.45 countries. Headquartered in London, Cerillion also has operations in India and Bulgaria, as well as sales presence in continental Europe, the USA, Singapore and Australia.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGZMZGMZGGKZM
Date   Source Headline
30th Nov 20226:29 pmRNSPDMR and PCA shareholding
30th Nov 202211:18 amRNSHolding(s) in Company
28th Nov 20227:00 amRNSFinal Results
23rd Nov 20227:00 amRNSNotice of Results and Investor Presentation
2nd Nov 20225:49 pmRNSHolding(s) in Company
2nd Nov 202212:40 pmRNSHolding(s) in Company
26th Oct 20227:00 amRNSRelease of latest version of flagship product set
24th Oct 20227:00 amRNSTrading Update
6th Oct 20227:00 amRNSAppointment of Joint Broker
25th Aug 20223:48 pmRNSGrant of Options
8th Aug 20223:08 pmRNSHolding(s) in Company
28th Jul 20224:35 pmRNSPrice Monitoring Extension
19th Jul 20227:00 amRNSHolding(s) in Company
6th Jul 20227:00 amRNSMajor Contract Win
13th May 20227:33 amRNSDirector Share Purchase
9th May 20227:00 amRNSInterim Results Presentation
9th May 20227:00 amRNSInterim Results
25th Apr 202210:13 amRNSHolding(s) in Company
19th Apr 20227:00 amRNSH1 2022 Trading Update
6th Apr 20227:00 amRNSCerillion Client MVN-X Reaches Million Subscribers
7th Mar 20227:00 amRNSWins Prestigious Megabuyte Performance Award
2nd Mar 20227:00 amRNSExercise of Options, PDMR Shareholding & TVR
21st Feb 20223:08 pmRNSHolding(s) in Company
21st Feb 20227:00 amRNSShare purchase for Employee Share Option Scheme
15th Feb 20227:00 amRNSRecognised in Two Gartner Market Guide Reports
4th Feb 202211:37 amRNSResult of AGM
31st Jan 20227:00 amRNSConfirmation of Board Appointment
27th Jan 20222:25 pmRNSHolding(s) in Company
24th Jan 20222:05 pmRNSSecond Price Monitoring Extn
24th Jan 20222:00 pmRNSPrice Monitoring Extension
10th Jan 20227:00 amRNSCompletion of Implementation for Norlys
14th Dec 20217:00 amRNSBoard Retirement and Proposed Appointment
26th Nov 20218:37 amRNSPDMR and PCA Shareholding
22nd Nov 20217:00 amRNSFinal Results
16th Nov 20212:42 pmRNSHolding(s) in Company
2nd Nov 20217:00 amRNSRelease of Cerillion 21.2
4th Oct 20217:02 amRNSTrading Update
28th Sep 20217:00 amRNSContracts worth £4.2m with OpenNet
23rd Sep 20216:15 pmRNSHolding(s) in Company
9th Sep 20217:00 amRNSOpening of Bulgaria office
8th Sep 20217:00 amRNSInvestor Presentation
22nd Jul 20214:24 pmRNSHolding(s) in Company
13th Jul 202111:03 amRNSHolding(s) in Company
6th Jul 202111:30 amRNSDirector/PDMR Shareholding
22nd Jun 20217:00 amRNSGrant of Options
18th Jun 20217:00 amRNSEmployee Share Option Scheme
10th Jun 202111:35 amRNSDirector/PDMR shareholding
27th May 20216:03 pmRNSReplacement: Director/PDMR Shareholding
27th May 20213:50 pmRNSDirector/PDMR Shareholding
24th May 20214:59 pmRNSExercise of Options and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.